Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
AbbVie
Atul Deodhar; Filip Van den Bosch; Denis Poddubnyy; Walter P Maksymowych; Désirée van der Heijde; Tae-Hwan Kim; Mitsumasa Kishimoto; Ricardo Blanco; Yuanyuan Duan; Yihan Li; Aileen L Pangan; Peter Wung; In-Ho Song